Table of Contents

company-logo

Xilio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies to improve the immune system of cancer patients. Its checkpoint inhibitor program includes XTX101, a clinical-stage, tumor-selective anti-CTLA-4 mAb that is in Phase 1/2 clinical trials in patients with solid tumors. The company also develops cytokine programs, which comprises XTX202, a modified form of IL-2; XTX301, an IL-12 product candidate; and XTX401, an IL-15 product candidate that are masked with a protein domain to prevent binding activity until cleaved off by tumor microenvironment (TME)-associated proteases. Xilio Therapeutics, Inc. was founded in 2016 and is headquartered in Waltham, Massachusetts.

Xilio Therapeutics Dividend Announcement

• Xilio Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Xilio Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Xilio Therapeutics Dividend History

Xilio Therapeutics Dividend Yield

Xilio Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Xilio Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Xilio Therapeutics Financial Ratios

P/E ratio-1.42
PEG ratio1.21
P/B ratio3.30
ROE-166.81%
Payout ratio0.00%
Current ratio1.67
Quick ratio1.67
Cash Ratio1.61

Xilio Therapeutics Dividend FAQ

Does Xilio Therapeutics stock pay dividends?
Xilio Therapeutics does not currently pay dividends to its shareholders.
Has Xilio Therapeutics ever paid a dividend?
No, Xilio Therapeutics has no a history of paying dividends to its shareholders. Xilio Therapeutics is not known for its dividend payments.
Why doesn't Xilio Therapeutics pay dividends?
There are several potential reasons why Xilio Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Xilio Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Xilio Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Xilio Therapeutics a dividend aristocrat?
Xilio Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Xilio Therapeutics a dividend king?
Xilio Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Xilio Therapeutics a dividend stock?
No, Xilio Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Xilio Therapeutics stocks?
To buy Xilio Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Xilio Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.